AWM
ADCT icon

Aviso Wealth Management’s ADC Therapeutics ADCT Stock Holding History

Aviso Wealth Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Hold
10,343
– – ﹤0.01% 144
2026
Q1 		$38.8K Hold
10,343
– – 0.02% 140
2025
Q4 		$36.5K Hold
10,343
– – 0.02% 146
2025
Q3 		$41.4K Hold
10,343
– – 0.02% 140
2025
Q2 		$27.7K Hold
10,343
– – 0.01% 144
2025
Q1 		$14.6K Hold
10,343
– – 0.01% 136
2024
Q4 		$20.6K Hold
10,343
– – 0.01% 143
2024
Q3 		$32.6K Hold
10,343
– – 0.02% 145
2024
Q2 		$32.7K Sell
10,343
-125
-1% -$497 0.02% 151
2024
Q1 		$47K Buy
+10,468
New +$38.6K 0.03% 148

Other funds holding ADCT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aviso Wealth Management's ADCT Position: Q2 2026 in Review

Aviso Wealth Management held its ADC Therapeutics (ADCT) position steady in Q2 2026 at 10,343 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #144.

Aviso Wealth Management first reported a position in ADCT in Q1 2024 and has held it in 10 quarters since. The position peaked at $47K in Q1 2024. 113 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

  • Aviso Wealth Management held 10,343 shares of ADC Therapeutics worth $11.1K as of Q2 2026.
  • Aviso Wealth Management left its ADC Therapeutics share count unchanged in Q2 2026.
  • ADC Therapeutics made up ﹤0.01% of Aviso Wealth Management's portfolio in Q2 2026, its #144 holding.
  • Aviso Wealth Management first reported a position in ADC Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Aviso Wealth Management's ADC Therapeutics position peaked at $47K in Q1 2024.
  • 113 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on Aviso Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.